MEDICAL EXERCISE INC.

MDXRdata completeness 63%2 fiscal years on file
i. The business — what you’d actually own
FigureFY 2025FY 2026
Revenue$1,2941—
Net income−$330,9852−$226,7082
Operating cash flow−$191,0273−$194,7513
Capital expenditure$3,8694—
Free cash flow (derived)−$194,8963—
Total debt——
Cash & equivalents$4505$43,4495
Diluted shares12.2M12.6M

Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).

ii. Your slice — ownership made literal
If you owned
shares
Net assets behind them
−$0.15
your share of equity
Profit it earned you last year
−$0.18
Free cash flow it threw off
—
Debt you’d be carrying
—

10 shares is a claim on −$0.15 of net worth that earned you −$0.18 last year.

iii. Is this a good business?
Moat signal · return on equity
— avg · 2y

Not enough data in the filings for a return-on-capital reading.

seeing a moat in the numbers →
Management signal · capital allocation
+3% shares · 2y

Share count is up 3% over 2 years — owners have been diluted. Worth asking what they got for it.

reading capital allocation →

Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.

iv. What it’s worth — engine v0.5.0
not applicable
only 1 years of FCF (need ≥3) — model not applicable
not applicable
only 1 years of FCF (need ≥3) — model not applicable
not applicable
only 2 years of net income (need ≥3)
not applicable
diluted EPS missing or non-positive — Graham Number undefined

Different models answer different questions — which to trust when →

Sources — the receipts
  1. 10-K · period ending 2025-03-31 · accession 0001213900-26-073032 (Revenues)
  2. 10-K · period ending 2025-03-31 · accession 0001213900-26-073032 (NetIncomeLoss)
  3. 10-K · period ending 2025-03-31 · accession 0001213900-26-073032 (NetCashProvidedByUsedInOperatingActivities)
  4. 10-K · period ending 2025-03-31 · accession 0001213900-26-073032 (PaymentsToAcquirePropertyPlantAndEquipment)
  5. 10-K · period ending 2025-03-31 · accession 0001213900-26-073032 (CashAndCashEquivalentsAtCarryingValue)